ReviewThe Journal of clinical and aesthetic dermatology2014
Malassezia (pityrosporum) folliculitis.
Review in The Journal of clinical and aesthetic dermatology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 33 citations in OpenAlex.
- Supramolecular Salicylic Acid Chemical Peeling Combined with Supramolecular Active Zinc for Malassezia Folliculitis: Efficacy and Safety from a Multicenter, Single-Arm Trial.Dermatology and therapy · 2026Article
- Review
- Review
- Navigating the Intersection of Lasers and the Skin Microbiome: A New Frontier in Esthetic Dermatology.Journal of cosmetic dermatology · 2025Article
- Article
- Card9 and MyD88 differentially regulate Th17 immunity to the commensal yeastbioRxiv : the preprint server for biology · 2024Article
- Scientific Rationale and Clinical Basis for Clindamycin Use in the Treatment of Dermatologic Disease.Antibiotics (Basel, Switzerland) · 2024Review
- Fungal coexistence in the skin mycobiome: a study involving Malassezia, Candida, and Rhodotorula.AMB Express · 2024Article
- Review
- Clinical characteristics and treatment outcomes of Pityrosporum folliculitis in immunocompetent patients.Archives of dermatological research · 2023Review
- Article
- [Clinical picture, causative agents and diagnostics of dermatomycoses].Dermatologie (Heidelberg, Germany) · 2022Article
- Malassezia Folliculitis following Triple Therapy for Cystic Fibrosis.Medicina (Kaunas, Lithuania) · 2022Article
- Review
- Truncal Acne: An Overview.Journal of clinical medicine · 2022Review
- Pityrosporum folliculitis in critically ill COVID-19 patients.Journal of the European Academy of Dermatology and Venereology : JEADV · 2022Article
- Is the Frequency of Seborrheic Dermatitis Related to Climate Parameters?Sisli Etfal Hastanesi tip bulteni · 2022Article
- Identification of cutaneous fungi and mites in adult atopic dermatitis: analysis by targeted 18S rRNA amplicon sequencing.BMC microbiology · 2021Article
- Article
- Examining 15% Azelaic Acid Foam for the Treatment of Folliculitis: A Pilot Study.The Journal of clinical and aesthetic dermatology · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Malassezia (Pityrosporum) folliculitis is a fungal acneiform condition commonly misdiagnosed as acne vulgaris. Although often associated with common acne, this condition may persist for years without complete resolution with typical acne medications. Malassezia folliculitis results from overgrowth of yeast present in the normal cutaneous flora. Eruptions may be associated with conditions altering this flora, such as immunosuppression and antibiotic use. The most common presentation is monomorphic papules and pustules, often on the chest, back, posterior arms, and face. Oral antifungals are the most effective treatment and result in rapid improvement. The association with acne vulgaris may require combinations of both antifungal and acne medications. This article reviews and updates readers on this not uncommon, but easily missed, condition.
Identifiers
24688625PMC3970831W1559912848What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.